Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients-Reference-Cited by-同舟云学术

Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients

Published:2017-04-20 Issue:8 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Gross Stefanie,Erdmann Michael,Haendle Ina,Voland Steve,Berger Thomas^ORCID,Schultz Erwin,Strasser Erwin,Dankerl Peter,Janka Rolf^ORCID,Schliep Stefan,Heinzerling Lucie,Sotlar Karl,Coulie Pierre,Schuler Gerold,Schuler-Thurner Beatrice

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/91438/files/pdf

Reference121 articles.

1. The Human Vaccines Project: A roadmap for cancer vaccine development

2. Vaccines for established cancer: overcoming the challenges posed by immune evasion

3. Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation

4. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

5. Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cell subsets and implications for cancer immunotherapy;Frontiers in Immunology;2024-06-05

2. Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial;Nature Communications;2024-02-23

3. Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development;Molecular Aspects of Medicine;2024-02

4. Immunotherapy: Constructive Approach for Breast Cancer Treatment;Breast Cancer: Targets and Therapy;2023-12

5. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations;Cells;2023-08-25